PF-04691502
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Serine/threonine-protein kinase mTOR inhibitor | no | 2 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Serine/threonine-protein kinase mTOR inhibitor | no | 2 | 0 |